Onqo Health

Onqo Health is a German startup offering digital health solutions aimed at enhancing oncology care and ensuring adherence to guidelines and best clinical practice. Their flagship product, EasyOncology, serves as a digital companion for oncologists, aiding them in identifying the appropriate therapy tailored to a specific diagnosis. The product is available as a smartphone app and is set to be integrated into tumor board software by the beginning of next year. Additionally, Onqo Health provides onqo, a digital tool designed for non-small cell lung cancer (NSCLC) patients, delivering personalized, medically relevant information throughout their treatment journey. The company's offerings are intended to provide an impartial solution, ensuring both healthcare professionals and patients feel secure in identifying the optimal treatment. Their products also support digital monitoring of guideline adherence for patients and offer decision support for healthcare professionals, potentially preventing treatment failures and, consequently, extending the survival of cancer patients. Notably, both EasyOncology and onqo have obtained the CE mark as MDD class I medical devices. Having been established in 2013, Onqo Health operates in the healthcare industry. Their most recent milestone includes securing a Seed Round investment on 25 August 2023, with the investment being led by Bertelsmann Investments and Isartal Ventures.